Published in J Exp Med on July 01, 1995
Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations. Antimicrob Agents Chemother (2005) 1.58
Chagas' disease and the autoimmunity hypothesis. Clin Microbiol Rev (1999) 1.18
Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc Natl Acad Sci U S A (1997) 1.10
Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase. Infect Immun (1999) 1.07
Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease. J Clin Invest (2001) 0.98
Receptor-activating autoantibodies and disease: preeclampsia and beyond. Expert Rev Clin Immunol (2011) 0.98
A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infect Immun (2004) 0.97
Infection, mimics, and autoimmune disease. J Clin Invest (2001) 0.94
Antibodies from Trypanosoma cruzi infected mice recognize the second extracellular loop of the beta 1-adrenergic and M2-muscarinic receptors and regulate calcium channels in isolated cardiomyocytes. Mol Cell Biochem (1997) 0.90
Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy. J Card Fail (2008) 0.89
Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2 beta protein in patients with chronic Chagas' heart disease. Clin Exp Immunol (2004) 0.88
Crystal structure of the complex mAb 17.2 and the C-terminal region of Trypanosoma cruzi P2β protein: implications in cross-reactivity. PLoS Negl Trop Dis (2011) 0.84
Modulation of cardiocyte functional activity by antibodies against trypanosoma cruzi ribosomal P2 protein C terminus. Infect Immun (2000) 0.83
Relevance of molecular mimicry in the mediation of infectious myocarditis. J Cardiovasc Transl Res (2013) 0.83
Role of autoantibodies in the physiopathology of Chagas' disease. Arq Bras Cardiol (2008) 0.83
Autoantibodies enhance agonist action and binding to cardiac muscarinic receptors in chronic Chagas' disease. J Recept Signal Transduct Res (2008) 0.82
Cytokine production but lack of proliferation in peripheral blood mononuclear cells from chronic Chagas' disease cardiomyopathy patients in response to T. cruzi ribosomal P proteins. PLoS Negl Trop Dis (2014) 0.81
Benzonidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children. PLoS One (2011) 0.80
Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease. Clin Diagn Lab Immunol (2001) 0.79
Antibodies in the pathogenesis of hypertension. Biomed Res Int (2014) 0.78
Three-dimensional studies of pathogenic peptides from the c-terminal of Trypanosoma cruzi ribosomal P proteins and their interaction with a monoclonal antibody structural model. PMC Biophys (2009) 0.78
Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy. J Clin Pathol (1999) 0.77
Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol (2007) 0.77
Are Agonistic Autoantibodies against G-Protein Coupled Receptors Involved in the Development of Long-Term Side Effects of Tumor Chemotherapy? Case Rep Oncol (2013) 0.75
Identification of reference genes in human myelomonocytic cells for gene expression studies in altered gravity. Biomed Res Int (2015) 0.75
Autoimmune disease triggered by infection with alphaproteobacteria. Expert Rev Clin Immunol (2009) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc Natl Acad Sci U S A (1987) 4.66
Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol Today (1993) 3.81
Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas' heart disease. Am J Trop Med Hyg (1989) 2.15
Fl-160. A surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue. J Exp Med (1989) 1.75
Chagas disease: a model for the study of autoimmune diseases. Parasitol Today (1989) 1.66
Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation (1994) 1.63
Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization. Proc Natl Acad Sci U S A (1987) 1.62
Very long charge runs in systemic lupus erythematosus-associated autoantigens. Proc Natl Acad Sci U S A (1991) 1.58
Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the alpha subunit. Proc Natl Acad Sci U S A (1988) 1.51
Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1993) 1.51
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1990) 1.44
Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest (1992) 1.37
Cloning and expression of Trypanosoma cruzi ribosomal protein P0 and epitope analysis of anti-P0 autoantibodies in Chagas' disease patients. J Exp Med (1992) 1.37
CHAGASIC MYOCARDIOPATHY. Prog Cardiovasc Dis (1964) 1.34
A circulating IgG in Chagas' disease which binds to beta-adrenoceptors of myocardium and modulates their activity. Clin Exp Immunol (1984) 1.27
Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol (1995) 1.17
Molecular mimicry by Trypanosoma cruzi: the F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc Natl Acad Sci U S A (1991) 1.15
Major Trypanosoma cruzi antigenic determinant in Chagas' heart disease shares homology with the systemic lupus erythematosus ribosomal P protein epitope. J Clin Microbiol (1990) 1.11
Humoral autoimmune response to ribosomal P proteins in chronic Chagas heart disease. Clin Exp Immunol (1991) 1.11
Antibodies to beta-adrenergic receptors disclosing agonist-like properties in idiopathic dilated cardiomyopathy and Chagas' heart disease. J Cardiovasc Electrophysiol (1994) 1.07
Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications. J Auton Nerv Syst (1994) 1.06
Molecular cloning and expression of the rat beta 1-adrenergic receptor gene. J Biol Chem (1990) 1.06
Trypanosoma cruzi: antibodies to a MAP-like protein in chronic Chagas' disease cross-react with mammalian cytoskeleton. Exp Parasitol (1991) 1.04
Cardiac antigen-specific autoantibody production is associated with cardiomyopathy in Trypanosoma cruzi-infected mice. J Immunol (1994) 1.02
Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. Clin Immunol Immunopathol (1994) 0.95
Mechanisms in cardiomyopathies. J Mol Cell Cardiol (1985) 0.94
Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins. J Immunol (1993) 0.90
The antigenic characteristics and the significance of the adenine nucleotide translocator as a major autoantigen to antimitochondrial antibodies in dilated cardiomyopathy. Adv Myocardiol (1985) 0.89
Characterization of the C-terminal region of a Trypanosoma cruzi 38-kDa ribosomal P0 protein that does not react with lupus anti-P autoantibodies. Immunol Lett (1992) 0.87
Primary muscle disease: definition of a 25-kDa polypeptide myopathic specific chagas antigen. Clin Immunol Immunopathol (1985) 0.83
Humoral autoimmune response in Chagas' disease: Trypanosoma cruzi ribosomal antigens as immunizing agents. FEMS Immunol Med Microbiol (1993) 0.83
Antibodies against ADP-ATP carrier enhance Ca2+ current in isolated cardiac myocytes. Am J Physiol (1988) 0.80
Polyreactive autoantibodies to negatively charged epitopes following Trypanosoma cruzi infection. Eur J Immunol (1992) 0.79
Distribution of antibodies against beta-adrenoceptors in the course of human Trypanosoma cruzi infection. Proc Soc Exp Biol Med (1991) 0.78
Trypanosoma cruzi: cellular and antibody response against the parasite in mice immunized with a 19-amino acid synthetic peptide. Exp Parasitol (1991) 0.78
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Changes in energy expenditure resulting from altered body weight. N Engl J Med (1995) 7.03
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med (1993) 5.67
A nondefective (competent) adenovirus-SV40 hybrid isolated from the AD.2-SV40 hybrid population. Proc Natl Acad Sci U S A (1969) 3.81
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother (1979) 3.61
Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation (1991) 2.97
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. V. Isolation of additional hybrids which differ in their simian virus 40-specific biological properties. J Virol (1973) 2.87
An unusual infection due to staphylococcus aureus. N Engl J Med (1971) 2.68
The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med (2000) 2.62
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation (2000) 2.57
Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med (1982) 2.37
Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin. Biochem Biophys Res Commun (1976) 2.29
Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology (1998) 2.26
Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation (1997) 2.16
Rapid detection of respiratory syncytial virus in nasopharyngeal secretions by enzyme-linked immunosorbent assay. J Clin Microbiol (1985) 2.10
Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J Exp Med (2001) 2.07
Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med (1983) 2.03
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. VII. Characterization of the simian virus 40 RNA species induced by five nondefective hybrid viruses. J Virol (1973) 2.02
Virus-specific nucleic acids in SV40-exposed hamster embryo cell lines: correlation with S and T antigens. Proc Natl Acad Sci U S A (1969) 1.97
Use of subgenomic poliovirus DNA hybridization probes to detect the major subgroups of enteroviruses. J Clin Microbiol (1984) 1.90
Detection of parasite DNA in Chagas' heart disease. Lancet (1995) 1.86
Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol (2001) 1.80
Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med (1994) 1.77
Herpes simplex virus type 1 DNA in cerebrospinal fluid of a patient with Mollaret's meningitis. N Engl J Med (1991) 1.69
Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis (1995) 1.66
Influence of tetramisole and its optical isomers on the mononuclear phagocytic system. Effect on carbon clearance in mice. J Reticuloendothel Soc (1973) 1.66
Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation (1997) 1.64
Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation (1994) 1.63
Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens. Infect Immun (1978) 1.60
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. 3. Base composition, molecular weight, and conformation of the Ad2+ND genome. J Virol (1971) 1.59
Immunoperoxidase visualisation of microtubules and microtubular proteins. Nature (1976) 1.56
The role of leptin in human physiology. N Engl J Med (1999) 1.55
Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol (2001) 1.55
Changes in life patterns and symptoms of low mood as reported by wives of severly brain-injured soldiers. J Consult Clin Psychol (1976) 1.54
Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1993) 1.51
Functional analysis of the intergenic regions of TcP2beta gene loci allowed the construction of an improved Trypanosoma cruzi expression vector. Gene (1999) 1.50
Molecular karyotype of clone CL Brener chosen for the Trypanosoma cruzi genome project. Mol Biochem Parasitol (1995) 1.48
Factors affecting the detection of enteroviruses in cerebrospinal fluid with coxsackievirus B3 and poliovirus 1 cDNA probes. J Clin Microbiol (1985) 1.47
Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J Infect Dis (1979) 1.46
Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America. J Clin Microbiol (1999) 1.45
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1990) 1.44
Interferon and transcription of early virus-specific RNA in cells infected with simian virus 40. Proc Natl Acad Sci U S A (1971) 1.43
Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci (2000) 1.42
Virus-specific deoxyribonucleic acid in simian virus 40-exposed hamster cells: correlation with S and T antigens. J Virol (1970) 1.42
PCR-based screening and lineage identification of Trypanosoma cruzi directly from faecal samples of triatomine bugs from northwestern Argentina. Parasitology (2006) 1.42
Interferon inhibits the in vitro accumulation of virus specific RNA in nuclei isolated from SV40 infected cells. Biochem Biophys Res Commun (1977) 1.41
Airborne transmission of chickenpox in a hospital. N Engl J Med (1980) 1.39
Nucleotide cDNA and complete deduced amino acid sequence of a Trypanosoma cruzi ribosomal P protein (P-JL5). Nucleic Acids Res (1990) 1.38
Nonisotopic oligomeric probes for the human enteroviruses. J Clin Microbiol (1988) 1.36
Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis (2012) 1.36
Inhibition of human herpesviruses by combination of acyclovir and human leukocyte interferon. Infect Immun (1981) 1.35
Evidence for reversible microclustering of lentil lectin membrane receptors on HeLa cells. FEBS Lett (1980) 1.34
Immunomodulatory properties of cystatins. Cell Mol Life Sci (2002) 1.34
Autonomic nervous system activity in weight gain and weight loss. Am J Physiol (1995) 1.33
Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage. J Neurosci (2000) 1.33
Mothering on crack cocaine: a grounded theory analysis. Soc Sci Med (1994) 1.32
A prospective study of risk factors for unipolar depression. J Abnorm Psychol (1988) 1.32
Effect of puberty on the relationship between circulating leptin and body composition. J Clin Endocrinol Metab (2000) 1.28
Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis (1998) 1.27
Development and application of RNA probes for the study of picornaviruses. Mol Cell Probes (1988) 1.27
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens (2000) 1.26
Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry. Proc Natl Acad Sci U S A (1985) 1.26
Effects of chronic weight perturbation on energy homeostasis and brain structure in mice. Am J Physiol Regul Integr Comp Physiol (2011) 1.25
The human carcinoma cell line A431 possesses large numbers of functional beta-adrenergic receptors. FEBS Lett (1984) 1.25
In vitro evaluations of condoms with and without nonoxynol 9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus type 2, and human immunodeficiency virus. Sex Transm Dis (1989) 1.25
Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis (1983) 1.24
Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation (2001) 1.23
Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation (2000) 1.22
Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics (1991) 1.21
Crime and punishment--the suicide pact. Arch Gen Psychiatry (1983) 1.21
Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet (1994) 1.21
Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B. J Infect Dis (1977) 1.18
Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol (2000) 1.18
RNA target loss during solid phase hybridization of body fluids--a quantitative study. Mol Cell Probes (1987) 1.18
Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Pediatr Infect Dis J (2001) 1.18
Alpha 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension (1997) 1.18
Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis J (1993) 1.17
Rapid herpes simplex virus susceptibility testing using an enzyme-linked immunosorbent assay performed in situ on fixed virus-infected monolayers. Antimicrob Agents Chemother (1987) 1.16
Clinical application of responder cell frequency estimates with four years of follow up. J Immunol Methods (1994) 1.16
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med (1982) 1.16
Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation (2001) 1.14
In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2. Antimicrob Agents Chemother (1992) 1.13
Proliferative and interferon responses by peripheral blood mononuclear cells after bone marrow transplantation in humans. Infect Immun (1978) 1.13
Expression of the transferrin gene during development of non-hepatic tissues: high level of transferrin mRNA in fetal muscle and adult brain. Biochem Biophys Res Commun (1984) 1.13
Fatal disseminated adenovirus infection in a renal transplant recipient. Am J Med (1975) 1.13
Use of an enzyme-linked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against varicella-zoster virus. Antimicrob Agents Chemother (1985) 1.13
Neonatal adenovirus infection: four patients and review of the literature. Pediatrics (1991) 1.12
Characterization, serological specificity, and diagnostic possibilities of monoclonal antibodies against Legionella pneumophila. J Clin Microbiol (1983) 1.12
Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res (1997) 1.12
The 70-kDa heat-shock protein is a major antigenic determinant in human Trypanosoma cruzi/Leishmania braziliensis braziliensis mixed infection. Immunol Lett (1992) 1.11
Major Trypanosoma cruzi antigenic determinant in Chagas' heart disease shares homology with the systemic lupus erythematosus ribosomal P protein epitope. J Clin Microbiol (1990) 1.11
Humoral autoimmune response to ribosomal P proteins in chronic Chagas heart disease. Clin Exp Immunol (1991) 1.11
Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation. Am J Transplant (2007) 1.11